119 related articles for article (PubMed ID: 32463029)
1. Dual-targeting RNA nanoparticles for efficient delivery of polymeric siRNA to cancer cells.
Kim T; Hyun HN; Heo R; Nam K; Yang K; Kim YM; Lee YS; An JY; Park JH; Choi KY; Roh YH
Chem Commun (Camb); 2020 Jun; 56(49):6624-6627. PubMed ID: 32463029
[TBL] [Abstract][Full Text] [Related]
2. Cationic cellulose nanocrystals complexed with polymeric siRNA for efficient anticancer drug delivery.
Kim YM; Lee YS; Kim T; Yang K; Nam K; Choe D; Roh YH
Carbohydr Polym; 2020 Nov; 247():116684. PubMed ID: 32829812
[TBL] [Abstract][Full Text] [Related]
3. Rolling circle transcription-based polymeric siRNA nanoparticles for tumor-targeted delivery.
Lee JH; Ku SH; Kim MJ; Lee SJ; Kim HC; Kim K; Kim SH; Kwon IC
J Control Release; 2017 Oct; 263():29-38. PubMed ID: 28373128
[TBL] [Abstract][Full Text] [Related]
4. Preparation of a Carrier to Achieve In Vivo Delivery of siRNA: The Example of Chitosan-Coated Poly(isobutylcyanoacrylate) Nanoparticles.
Vauthier C
Methods Mol Biol; 2019; 1974():181-194. PubMed ID: 31099003
[TBL] [Abstract][Full Text] [Related]
5. Delivery of siRNA to ovarian cancer cells using laser-activated carbon nanoparticles.
Sengupta A; Mezencev R; McDonald JF; Prausnitz MR
Nanomedicine (Lond); 2015; 10(11):1775-84. PubMed ID: 26080699
[TBL] [Abstract][Full Text] [Related]
6. Nanoengineered Polymeric RNA Nanoparticles for Controlled Biodistribution and Efficient Targeted Cancer Therapy.
Kim T; Han HS; Yang K; Kim YM; Nam K; Park KH; Choi SY; Park HW; Choi KY; Roh YH
ACS Nano; 2024 Mar; 18(11):7972-7988. PubMed ID: 38445578
[TBL] [Abstract][Full Text] [Related]
7. Tumor-targeting multifunctional nanoparticles for siRNA delivery: recent advances in cancer therapy.
Ku SH; Kim K; Choi K; Kim SH; Kwon IC
Adv Healthc Mater; 2014 Aug; 3(8):1182-93. PubMed ID: 24577795
[TBL] [Abstract][Full Text] [Related]
8. Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy.
Li TS; Yawata T; Honke K
Eur J Pharm Sci; 2014 Feb; 52():48-61. PubMed ID: 24178005
[TBL] [Abstract][Full Text] [Related]
9. Confocal microscopy for the analysis of siRNA delivery by polymeric nanoparticles.
Portis AM; Carballo G; Baker GL; Chan C; Walton SP
Microsc Res Tech; 2010 Sep; 73(9):878-85. PubMed ID: 20803695
[TBL] [Abstract][Full Text] [Related]
10. Surface-Functionalized Polymeric siRNA Nanoparticles for Tunable Targeting and Intracellular Delivery to Hematologic Cancer Cells.
Kwak E; Kim T; Yang K; Kim YM; Han HS; Park KH; Choi KY; Roh YH
Biomacromolecules; 2022 Jun; 23(6):2255-2263. PubMed ID: 35362323
[TBL] [Abstract][Full Text] [Related]
11. Chitosan coated polylactic acid nanoparticle-mediated combinatorial delivery of cisplatin and siRNA/Plasmid DNA chemosensitizes cisplatin-resistant human ovarian cancer cells.
Babu A; Wang Q; Muralidharan R; Shanker M; Munshi A; Ramesh R
Mol Pharm; 2014 Aug; 11(8):2720-33. PubMed ID: 24922589
[TBL] [Abstract][Full Text] [Related]
12. Revisiting the value of competition assays in folate receptor-mediated drug delivery.
Jones SK; Sarkar A; Feldmann DP; Hoffmann P; Merkel OM
Biomaterials; 2017 Sep; 138():35-45. PubMed ID: 28551461
[TBL] [Abstract][Full Text] [Related]
13. A Collaborative Assembly Strategy for Tumor-Targeted siRNA Delivery.
Sun Q; Kang Z; Xue L; Shang Y; Su Z; Sun H; Ping Q; Mo R; Zhang C
J Am Chem Soc; 2015 May; 137(18):6000-10. PubMed ID: 25869911
[TBL] [Abstract][Full Text] [Related]
14. An organotypic model of high-grade serous ovarian cancer to test the anti-metastatic potential of ROR2 targeted Polyion complex nanoparticles.
Joshi N; Liu D; Dickson KA; Marsh DJ; Ford CE; Stenzel MH
J Mater Chem B; 2021 Nov; 9(44):9123-9135. PubMed ID: 34676865
[TBL] [Abstract][Full Text] [Related]
15. Bioconjugated gold nanoparticles enhance cellular uptake: A proof of concept study for siRNA delivery in prostate cancer cells.
Guo J; O'Driscoll CM; Holmes JD; Rahme K
Int J Pharm; 2016 Jul; 509(1-2):16-27. PubMed ID: 27188645
[TBL] [Abstract][Full Text] [Related]
16. Post-Transcriptional Regulation of the GASC1 Oncogene with Active Tumor-Targeted siRNA-Nanoparticles.
Movassaghian S; Xie Y; Hildebrandt C; Rosati R; Li Y; Kim NH; Conti DS; da Rocha SR; Yang ZQ; Merkel OM
Mol Pharm; 2016 Aug; 13(8):2605-21. PubMed ID: 27223606
[TBL] [Abstract][Full Text] [Related]
17. Selective delivery of PLXDC1 small interfering RNA to endothelial cells for anti-angiogenesis tumor therapy using CD44-targeted chitosan nanoparticles for epithelial ovarian cancer.
Kim GH; Won JE; Byeon Y; Kim MG; Wi TI; Lee JM; Park YY; Lee JW; Kang TH; Jung ID; Shin BC; Ahn HJ; Lee YJ; Sood AK; Han HD; Park YM
Drug Deliv; 2018 Nov; 25(1):1394-1402. PubMed ID: 29890852
[TBL] [Abstract][Full Text] [Related]
18. Stimuli-Responsive Polymer-Prodrug Hybrid Nanoplatform for Multistage siRNA Delivery and Combination Cancer Therapy.
Saw PE; Yao H; Lin C; Tao W; Farokhzad OC; Xu X
Nano Lett; 2019 Sep; 19(9):5967-5974. PubMed ID: 31381852
[TBL] [Abstract][Full Text] [Related]
19. Peptide-based targeted polymeric nanoparticles for siRNA delivery.
Hussein WM; Cheong YS; Liu C; Liu G; Begum AA; Attallah MA; Moyle PM; Torchilin VP; Smith R; Toth I
Nanotechnology; 2019 Oct; 30(41):415604. PubMed ID: 31295734
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of PLGA-Lipid Hybrid Nanoparticles for siRNA Delivery Using the Emulsion Method PLGA-PEG-Lipid Nanoparticles for siRNA Delivery.
Wang L; Griffel B; Xu X
Methods Mol Biol; 2017; 1632():231-240. PubMed ID: 28730443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
